BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15905175)

  • 21. A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation.
    Yahata Y; Shirakata Y; Tokumaru S; Yang L; Dai X; Tohyama M; Tsuda T; Sayama K; Iwai M; Horiuchi M; Hashimoto K
    J Biol Chem; 2006 May; 281(19):13209-13216. PubMed ID: 16543233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
    Higashiyama S; Nanba D
    Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
    Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
    Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme.
    Merlos-Suárez A; Ruiz-Paz S; Baselga J; Arribas J
    J Biol Chem; 2001 Dec; 276(51):48510-7. PubMed ID: 11600492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
    Mori S; Tanaka M; Nanba D; Nishiwaki E; Ishiguro H; Higashiyama S; Matsuura N
    J Biol Chem; 2003 Nov; 278(46):46029-34. PubMed ID: 12952982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK.
    Eguchi S; Dempsey PJ; Frank GD; Motley ED; Inagami T
    J Biol Chem; 2001 Mar; 276(11):7957-62. PubMed ID: 11116149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
    Umata T; Hirata M; Takahashi T; Ryu F; Shida S; Takahashi Y; Tsuneoka M; Miura Y; Masuda M; Horiguchi Y; Mekada E
    J Biol Chem; 2001 Aug; 276(32):30475-82. PubMed ID: 11402047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
    Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
    Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metalloprotease-mediated HB-EGF release regulates EGF receptor transactivation in A431 cells under oxidative stress].
    Smirnova IS; Gonchar IV; Shatrova AN; Nikol'skiĭ NN; Burova EB
    Tsitologiia; 2010; 52(5):357-63. PubMed ID: 20586269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
    Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
    J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
    Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
    J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells.
    Xu KP; Ding Y; Ling J; Dong Z; Yu FS
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):813-20. PubMed ID: 14985295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Membrane-anchored heparin-binding EGF-like growth factor processing by ADAM12 in cardiac hypertrophy].
    Higashiyama S
    Nihon Rinsho; 2003 May; 61(5):767-75. PubMed ID: 12755001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
    Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
    Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor.
    Xu KP; Yin J; Yu FS
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):636-43. PubMed ID: 17251460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C.
    Dethlefsen SM; Raab G; Moses MA; Adam RM; Klagsbrun M; Freeman MR
    J Cell Biochem; 1998 May; 69(2):143-53. PubMed ID: 9548562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
    Horiuchi K; Le Gall S; Schulte M; Yamaguchi T; Reiss K; Murphy G; Toyama Y; Hartmann D; Saftig P; Blobel CP
    Mol Biol Cell; 2007 Jan; 18(1):176-88. PubMed ID: 17079736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
    Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
    Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II.
    Takaguri A; Shirai H; Kimura K; Hinoki A; Eguchi K; Carlile-Klusacek M; Yang B; Rizzo V; Eguchi S
    J Mol Cell Cardiol; 2011 Mar; 50(3):545-51. PubMed ID: 21172357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells.
    Uchiyama-Tanaka Y; Matsubara H; Mori Y; Kosaki A; Kishimoto N; Amano K; Higashiyama S; Iwasaka T
    Kidney Int; 2002 Sep; 62(3):799-808. PubMed ID: 12164862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.